Key result
Mechanical valves increase 11-year bleeding risk ~60% vs. bioprostheses without improving survival.
Why the study?
Long-term comparative outcomes of mechanical valves versus bioprostheses in randomized patients were not well established.
Does mechanical valve prosthesis compared to bioprosthesis improve survival or alter complication rates in patients requiring valve replacement?
Population
1,229 patients from 3 randomized clinical trials
Comparison
Mechanical valve prostheses vs bioprosthetic valves
Design
Meta-analysis of randomized clinical trials
Follow-up
Up to 11 years
Authors
Loading...
May favor bioprostheses to reduce bleeding without survival penalty; reinforces Level 1 evidence guiding individualized valve selection.
Meta-Analysis (n=1,229)
Does mechanical valve prosthesis compared to bioprosthesis improve survival or alter complication rates in patients requiring valve replacement?
Relative Risk: 1.6 (95% CI 1.2–2.2)
p-value: p=<0.001
Mechanical and bioprosthetic valves offer similar long-term survival, but mechanical valves carry a higher risk of bleeding and endocarditis, whereas bioprostheses have a higher risk of reoperation.
Kassaï et al. (2000) conducted a meta-analysis in Valvular heart disease requiring replacement (n=1,229). Mechanical valves vs. Bioprosthesis was evaluated on Bleeding at 11 years (RR 1.6, 95% CI 1.2-2.2, p=<0.001). Mechanical valves increased the risk of bleeding at 11 years compared to bioprostheses (RR 1.6; 95% CI 1.2-2.2; P<0.001), but valve type did not significantly influence survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: